PCOS and Insulin Resistance: The Connection Indian Patients Need to Know | ALIV

Insulin resistance is present in approximately 70-80% of women with PCOS — making it the most common metabolic feature of the condition and one of the most important targets for management. Yet most PCOS patients in India are told about their ovarian cysts, given guidance on their periods, and sent away without a fasting insulin test. The absence of this investigation leaves the majority of patients without information on the most treatable aspect of their PCOS biology.

What Insulin Resistance Means in the Context of PCOS

Insulin is the hormone produced by the pancreas in response to blood glucose — it signals cells to take up glucose from the bloodstream. Insulin resistance means that the body's cells respond sub-optimally to insulin, requiring the pancreas to produce more insulin to achieve the same glucose-lowering effect. Elevated circulating insulin — hyperinsulinaemia — directly stimulates the ovaries to produce more androgens (testosterone) than normal. This is the central molecular link between insulin resistance and PCOS: the insulin excess drives androgen excess, which drives the hormonal features of the syndrome — irregular ovulation, acne, hirsutism, and the polycystic ovarian morphology itself.

This means that improving insulin sensitivity is not just managing a metabolic risk factor — it is directly treating one of the root drivers of PCOS hormonal disturbance. This is why lifestyle interventions that improve insulin sensitivity (dietary changes, exercise, targeted supplementation) often produce meaningful improvements in menstrual regularity and androgen-related symptoms alongside any weight changes.

How to Test for Insulin Resistance

Fasting blood glucose alone is insufficient — it can be completely normal even in significant insulin resistance, because the pancreas compensates by producing enough extra insulin to keep glucose in range. The appropriate assessments are: fasting insulin (ideally below 10 mU/L, with values above 15 suggesting significant resistance); the HOMA-IR calculation (fasting glucose x fasting insulin / 405, with above 2.0-2.5 indicating insulin resistance); and an oral glucose tolerance test with insulin levels at 0, 60, and 120 minutes in patients where the picture is ambiguous. See the complete metabolic marker guide: metabolic blood markers that actually matter.

The Androgen Connection

Hyperinsulinaemia — elevated insulin from insulin resistance — activates androgen production in the ovaries through two mechanisms: direct stimulation of ovarian theca cells (which produce testosterone and androstenedione) via insulin receptors; and suppression of sex hormone-binding globulin (SHBG) in the liver. SHBG normally binds free testosterone in circulation, reducing its biological activity. When SHBG is suppressed by high insulin, free testosterone rises and produces the clinical signs of androgen excess — acne along the jaw and chin, excess facial and body hair, and scalp hair thinning in an androgenetic pattern.

This mechanism explains why PCOS treatment that improves insulin sensitivity — whether through lifestyle change, metformin, inositol supplementation, or combined approaches — often produces visible improvement in androgen-related skin symptoms alongside menstrual and metabolic improvements. Treating the root insulin problem produces downstream androgen improvement. See: the full PCOS support guide.

Nutritional and IV Support for Insulin Resistance in PCOS

Beyond dietary modification and exercise — the foundational interventions — several targeted nutritional approaches have specific clinical evidence in PCOS-related insulin resistance:

Myo-inositol: The form of inositol with the strongest PCOS evidence base. It is a second-messenger in insulin signalling — deficiency impairs insulin receptor function. Supplementation at 2-4g per day, often combined with D-chiro-inositol (the liver-produced metabolite of myo-inositol), improves insulin sensitivity, restores ovulation, and reduces androgen levels in multiple randomised controlled trials. Inositol is part of ALIV's PCOS Balancer IV formulation.

Magnesium: Magnesium is a cofactor in over 300 enzymatic reactions including the insulin receptor signalling pathway. Magnesium deficiency — common in the Indian urban diet — is independently associated with insulin resistance and PCOS severity. IV magnesium achieves the highest replenishment rates for patients with significant deficiency.

N-acetylcysteine (NAC): NAC has a growing evidence base in PCOS, improving insulin sensitivity and ovulation outcomes in small but consistent trials. It also replenishes glutathione, addressing the oxidative stress dimension of PCOS.

Does insulin resistance mean I will develop diabetes?

Not inevitably — but it does represent an elevated risk, particularly in the South Asian population which has inherently higher diabetes susceptibility than European populations at equivalent BMI. PCOS patients with insulin resistance who do not address the metabolic driver have a significantly elevated lifetime risk of type 2 diabetes and cardiovascular disease. This is one of the most important reasons to take insulin resistance seriously as part of PCOS management — not just for periods and fertility, but for long-term metabolic health.

Can a thin woman with PCOS have insulin resistance?

Yes — lean PCOS patients can have significant insulin resistance despite normal BMI, though it tends to be less severe than in overweight PCOS patients. Lean PCOS-related insulin resistance is often characterised by relatively high fasting insulin with normal fasting glucose — a pattern that standard glucose-only testing misses entirely. Fasting insulin is essential in all PCOS patients regardless of body weight.

How quickly does insulin sensitivity improve with treatment?

With dietary change, exercise, and inositol supplementation, measurable improvement in fasting insulin is typically seen at eight to twelve weeks. Weight loss of 5-10% of body weight (in overweight PCOS patients) produces significant insulin sensitivity improvement and is associated with improved menstrual regularity in multiple studies. The improvement is dose-dependent on the lifestyle change magnitude — modest changes produce modest improvement; consistent, sustained changes produce meaningful metabolic benefit.

Is inositol supplementation safe during pregnancy?

Myo-inositol is used in some fertility protocols during ovulation induction — it is generally considered safe in early pregnancy and some practitioners continue it in the first trimester for patients with PCOS who conceive. However, any supplementation during pregnancy should be discussed with your obstetric team rather than continued based on general wellness guidance. Do not continue PCOS supplementation into pregnancy without explicit obstetric guidance.